U.S. Physical Therapy (NYSE:USPH - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $0.70 per share and revenue of $190.24 million for the quarter.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The company had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. During the same quarter in the previous year, the firm posted $0.51 EPS. The firm's quarterly revenue was up 18.0% on a year-over-year basis. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
U.S. Physical Therapy Trading Down 4.0%
Shares of USPH stock opened at $70.21 on Monday. The firm has a market capitalization of $1.07 billion, a PE ratio of 32.21, a price-to-earnings-growth ratio of 3.39 and a beta of 1.45. The stock has a fifty day moving average of $76.20 and a two-hundred day moving average of $77.40. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $101.19.
U.S. Physical Therapy Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a yield of 2.6%. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.
Wall Street Analyst Weigh In
A number of analysts have issued reports on the company. JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research reaffirmed an "outperform" rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy presently has an average rating of "Moderate Buy" and an average target price of $109.00.
Read Our Latest Stock Analysis on USPH
Insider Activity at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the firm's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director owned 2,594 shares in the company, valued at approximately $202,357.94. This trade represents a 13.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company's stock.
Institutional Trading of U.S. Physical Therapy
A number of hedge funds have recently modified their holdings of USPH. Royal Bank of Canada lifted its position in shares of U.S. Physical Therapy by 3.4% during the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company's stock worth $5,733,000 after buying an additional 2,594 shares during the period. Jane Street Group LLC lifted its position in shares of U.S. Physical Therapy by 249.3% during the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company's stock worth $3,568,000 after buying an additional 35,191 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of U.S. Physical Therapy by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company's stock worth $644,000 after buying an additional 391 shares during the period.
About U.S. Physical Therapy
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.